Acceleron Competitors or Alternatives

Acceleron's top competitors include Sangamo, bluebird bio and Orchard Therapeutics.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Acceleron's company profile

Habib Dable

President & CEO

93/100
250 - 500
$165.4M
$100M - 500M
1
Acceleron's Competitor - Sangamo logo

Sandy Macrae

President & CEO

68/100
480
$71.5M
$57.8M
2
Acceleron's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
3
Acceleron's Competitor - Orchard Therapeutics logo

Bobby Gaspar

Founder & CEO

79/100
100 - 250
$524.7M
$5M - 25M
4
Acceleron's Competitor - Agios logo

Brian Goff

CEO

85/100
390
$226M
$36.5M
5
Acceleron's Competitor - Lpath logo

Gary J. G. Atkinson

CEO

69/100
100 - 250
$17.4M
$25M - 100M

Acceleron VS Sangamo

Sangamo is a top competitor of Acceleron. Sangamo is a Public company that was founded in 1995 in Brisbane, California. Sangamo operates in the Biotechnology industry. Compared to Acceleron, Sangamo has 168 more employees.

Acceleron VS bluebird bio

bluebird bio is seen as one of Acceleron's biggest rivals. bluebird bio was founded in 1992, and is headquartered in Somerville, Massachusetts. bluebird bio is in the Biotechnology industry. bluebird bio generates $29M less revenue vs. Acceleron.

Acceleron VS Orchard Therapeutics

Orchard Therapeutics is seen as one of Acceleron's top competitors. Orchard Therapeutics was founded in London, England} in 2015. Orchard Therapeutics competes in the Biotechnology industry. Compared to Acceleron, Orchard Therapeutics generates $94.8M less revenue.

Frequently Asked Questions about Acceleron

  1. Who are Acceleron's top competitors?

    Acceleron's top 3 competitors are Sangamo, bluebird bio, Orchard Therapeutics.
  2. Who is similar to Acceleron?

    Sangamo is the most similar to Acceleron. bluebird bio and Orchard Therapeutics are also similar to Acceleron.
  1. Are Acceleron and Sangamo competitors?

    Yes, Sangamo is one of Acceleron’s top competitors.